CompletedNot applicableNCT00006133
Randomized Study of Oral Contraceptives or Hormone Replacement Therapy in Women With Systemic Lupus Erythematosus
Studying Systemic lupus erythematosus
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- National Center for Research Resources (NCRR)
- Principal Investigator
- Graciela S. Alarcon, MDUniversity of Alabama at Birmingham
- Intervention
- estradiol(drug)
- Enrollment
- 970 enrolled
- Eligibility
- 0 years · FEMALE
- Timeline
- 2000
Study locations (17)
- University of Alabama Comprehensive Cancer Center, Birmingham, Alabama, United States
- University of California Los Angeles, Los Angeles, California, United States
- University of California-San Francisco, San Francisco, California, United States
- Pritzker School of Medicine, Chicago, Illinois, United States
- Louisiana State University School of Medicine, Shreveport, Louisiana, United States
- Johns Hopkins University School of Medicine, Baltimore, Maryland, United States
- University of Michigan Health Systems, Ann Arbor, Michigan, United States
- Hospital for Joint Diseases, New York, New York, United States
- Saint Luke's-Roosevelt Hospital Center, New York, New York, United States
- Hospital for Special Surgery, New York, New York, United States
- Rheumatology Associates of Long Island, Port Jefferson Station, New York, United States
- Montefiore Medical Center, The Bronx, New York, United States
- University of North Carolina, Chapel Hill, North Carolina, United States
- University of Pennsylvania, Philadelphia, Pennsylvania, United States
- University of Pittsburgh, Pittsburgh, Pennsylvania, United States
- +2 more locations on ClinicalTrials.gov
Collaborators
University of Alabama at Birmingham
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00006133 on ClinicalTrials.govOther trials for Systemic lupus erythematosus
Additional recruiting or active studies for the same condition.
- RECRUITINGEARLY PHASE1NCT07107659Safety and Efficacy of ONT01 in LupusHospital for Special Surgery, New York
- RECRUITINGNANCT07558850Exploratory Clinical Study of Anti-CD19/BCMA Universal CAR-T Cell Injection for the Treatment of Refractory Autoimmune DiseasesThe First Affiliated Hospital with Nanjing Medical University
- RECRUITINGNCT06948110Deciphering the Genetic Architecture of Autoimmune DiseasesNational Human Genome Research Institute (NHGRI)
- RECRUITINGPHASE2NCT07409181A Study to Test Whether Different Doses of BI 3000202 Help People With Systemic Lupus Erythematosus (SLE)Boehringer Ingelheim
- RECRUITINGPHASE3NCT07332481A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic DiseaseEMD Serono Research & Development Institute, Inc.
- RECRUITINGEARLY PHASE1NCT07526350MTS109 in Patients With Refractory Autoimmune DiseasesShanghai Changzheng Hospital
- RECRUITINGEARLY PHASE1NCT07490041Exploratory Clinical Study on the Safety and Efficacy of Anti- CD19/BCMA CAR-NK Cell Injection for the Treatment of Refractory Pediatric Rheumatic DiseasesThe Children's Hospital of Zhejiang University School of Medicine
- RECRUITINGNANCT07470151Clinical Study of EVM18001 in the Treatment of Refractory Autoimmune DiseasesUnion Hospital, Tongji Medical College, Huazhong University of Science and Technology